PRESS-RELEASE ·Filed May 4, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the upcoming earnings release on May 11 for updates on clinical progress and financial metrics. No immediate trading catalyst.
Final — all horizons settled through T+60d
BCAX ▲ +13.95% at T+60d
NEUTRAL call ✓ call won +13.95% · α vs SPY +12.10% · entry $22.72 → $25.89
T+1d
+1.94%
call +1.94% · α +1.14%
$23.16
settled 5mo ago
T+5d
+0.88%
call +0.88% · α -2.06%
$22.92
settled 5mo ago
T+20d
-9.24%
call -9.24% · α -14.89%
$20.62
settled 4mo ago
T+60d
+13.95%
call +13.95% · α +12.10%
$25.89
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Bicara Therapeutics announced it will report Q1 2026 financial results on May 11, 2026, with a conference call. This is a routine scheduling announcement and contains no financial data or new material information.
Key Facts
- Bicara will report Q1 2026 results on May 11, 2026.
- Conference call scheduled for 8:30 a.m. ET the same day.
Financial Impact
Not specified
Risk Factors
- Clinical trial risks for ficerafusp alfa.
- Cash burn rate and potential future capital needs.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (20 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3286695 |
20 reports for BCAX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 8-K | $24.73 $19.78 | ▼ −20.02% | ▼ −20.24% | $18.25 (−26.18%) |
Aug 14, 2026 7w ago | Press Release | $24.28 $23.20 | ▼ −4.45% | ▼ −2.46% | $18.25 (−24.81%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 11, 2026 7w ago | 8-K | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Aug 11, 2026 7w ago | Press Release | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Jul 14, 2026 11w ago | Insider Cluster | $28.10 $23.76 | ▼ −15.44% | ▼ −17.94% | $18.25 (−35.04%) |
Jun 11, 2026 16w ago | Institutional Cluster | $21.28 $29.68 | ▼ −39.47% | ▼ −37.58% | $18.25 (+14.22%) |
May 26, 2026 18w ago | Insider Cluster | $21.58 $26.34 | ▲ +22.06% | ▲ +23.96% | $18.25 (−15.41%) |
May 11, 2026 20w ago | 8-K | $22.92 $20.56 | ▼ −10.30% | ▼ −9.99% | $18.25 (−20.35%) |
Showing 10 of 20
US Market Status
Market Open — Closes in 3h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access